Orange Book product · Generic (ANDA)
TICAGRELOR
TICAGRELOR
At a glance
Mar 24, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 24, 2026
3 mo ago
Today
Pharmaceutical detail
Active ingredient
TICAGRELOR
Strength
60MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 219006
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TICAGRELOR
- 2015BRILINTABrand (NDA)
NDA 022433 · ASTRAZENECA
- 2026TICAGRELORGeneric (ANDA)
ANDA 208539 · MICRO LABS
- 2026TICAGRELORGeneric (ANDA)
ANDA 217679 · MANKIND PHARMA
- 2025TICAGRELORGeneric (ANDA)
ANDA 208576 · ALEMBIC
- 2025TICAGRELORGeneric (ANDA)
ANDA 210219 · ALKEM LABS LTD
- 2025TICAGRELORGeneric (ANDA)
ANDA 208531 · AMNEAL
- 2025TICAGRELORGeneric (ANDA)
ANDA 208584 · APOTEX
- 2025TICAGRELORGeneric (ANDA)
ANDA 216187 · CHANGZHOU PHARM
- 2025TICAGRELORGeneric (ANDA)
ANDA 208541 · DR REDDYS
- 2025TICAGRELORGeneric (ANDA)
ANDA 208537 · INVAGEN PHARMS
- 2025TICAGRELORGeneric (ANDA)
ANDA 212258 · MACLEODS PHARMS LTD
- 2025TICAGRELORGeneric (ANDA)
ANDA 208596 · MSN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
